Casatest vivo

In vivo tests - UB-CARE ITALY

Por um escritor misterioso
Last updated 13 abril 2025
In vivo tests - UB-CARE ITALY
In vivo tests - UB-CARE ITALY
Profiling ubiquitin signalling with UBIMAX reveals DNA damage- and SCFβ-Trcp1-dependent ubiquitylation of the actin-organizing protein Dbn1
In vivo tests - UB-CARE ITALY
IJMS, Free Full-Text
In vivo tests - UB-CARE ITALY
Bioprinting: From Tissue and Organ Development to in Vitro Models
In vivo tests - UB-CARE ITALY
Electrostatic and steric effects underlie acetylation-induced changes in ubiquitin structure and function
In vivo tests - UB-CARE ITALY
UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology
In vivo tests - UB-CARE ITALY
In vitro efficacy - UB-CARE ITALY
In vivo tests - UB-CARE ITALY
In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas
In vivo tests - UB-CARE ITALY
Frontiers Animal Models of Neurodegenerative Disease: Recent Advances in Fly Highlight Innovative Approaches to Drug Discovery
In vivo tests - UB-CARE ITALY
Gels, Free Full-Text
In vivo tests - UB-CARE ITALY
UB-CARE - Sperimentazioni in vitro, analisi, biosafety
In vivo tests - UB-CARE ITALY
Molecular and in vivo studies of a glutamate-class prolyl-endopeptidase for coeliac disease therapy
In vivo tests - UB-CARE ITALY
Development of NanoLuc-targeting protein degraders and a universal reporter system to benchmark tag-targeted degradation platforms
Recomendado para você
você pode gostar

© 2014-2025 likytut.eu. All rights reserved.